Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report-Reference-Cited by-同舟云学术

Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report

Published:2015-12 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Bongiovanni Alberto,Riva Nada,Ricci Marianna,Mercatali Laura,Liverani Chiara,La Manna Federico,De Vita Alessandro,Cavaliere Davide,Pieri Federica,Oboldi Devil,Verdecchia Giorgio Maria,Amadori Dino,Ibrahim Toni

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-015-2038-7.pdf

Reference35 articles.

1. Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Péoc'h M, Istier L, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One. 2011;6:e20294.

2. Terada T. Leiomyoma of the kidney parenchyma. Pathol Int. 2011;61:495–97.

3. Moletta L, Sperti C, Beltrame V, Gruppo M, Blandamura S, Pasquali C, et al. Leiomyosarcoma of the pancreas with liver metastases as a paradigm of multimodality treatment: case report and review of the literature. J Gastrointest Cancer. 2012;43:246–50.

4. Chen J, Wei R, Ma X. Orbital metastasis of retroperitoneal leiomyosarcoma. Med Oncol. 2012;29:392–5.

5. Tanboon J, Keskool P. Leiomyosarcoma: a rare tumor of the thyroid. Endocr Pathol. 2013;24:136–43.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of cancer nanotechnology in the panorama of sarcoma;Frontiers in Bioengineering and Biotechnology;2022-10-17

2. Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO);Gynecologic Oncology Reports;2020-08

3. Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response;Current Drug Targets;2020-07-28

4. Long-Term Progression-Free Survival in a Patient with Metastatic Leiomyosarcoma of the Inguinal Region Treated with Trabectedin;Case Reports in Oncology;2018-04-19

5. Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report;Case Reports in Oncology;2018-02-09